课题基金 / 基金详情

Modulation of gene expression of transforming growth factor-α by ethanol in ethano-exposed hepatocytes

Modulation of gene expression of transforming growth factor-α by ethanol in ethano-exposed hepatocytes
乙醇对暴露于乙醇的肝细胞中转化生长因子-α基因表达的调节
批准号:
11670519
负责人:
KATO Junji
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

KATO Junji的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Liver fibrosis often develops in alcoholic liver diseases without accompanying inflammation, however the underlying mechanism is unclear. Using ethanol-exposed human HepG2 hepatoblastoma cells as a model for alcoholic liver diseases, we found previously that ethanol exposure causes HepG2 cells to secrete transforming growth factor-α (TGF-α) which stimulates collagen synthesis in human IMR-90 fibroblasts and rat hepatic stellate cells. The aim of this study was to investigate the mechanism of TGF-α gene expression by ethanol. TGF-α mRNA and protein expression by Northern and Western bolt, respectively. Gel mobility shift assay for NF-kB for the promotor region of TGF-α gene was examined. Northern and Western blot analyses showed increased TGF-α mRNA and protein expression in ethanol-treated HepG2 cells. Ethanol-treatment increased degradation of IkB and enhanced TGF-α transcription via NF-kB.Ethano-induced NF-kB activation and TGF-α transcription were blocked in the presence of anti-oxidant, NAC, suggesting that production of reactive oxygen species is inplicated in this signaling. In conclusion, TGF-α is considered to contribute to the development of hepatic fibrosis in alcoholic liver diseases.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
Lu L,Sakamaki S,Kato J, et al: "Prevention of lethal acute graft-versus-host disease in mice by oral administration of T helper 1 inhibitor,TAK-603."Blood. 97. 1123-1130 (2001)
Lu L、Sakamaki S、Kato J 等人:“通过口服 T 辅助细胞 1 抑制剂 TAK-603 预防小鼠致命性急性移植物抗宿主病。”血液。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Matsunaga T, Sakamaki S, Kato J, et al.: "Use of PCR serum in diagnosing and monitoring cytomegalovirus reactivation in bone marrow transplant recipients."Int J Hematol. 69. 105-111 (1999)
Matsunaga T、Sakamaki S、Kato J 等人:“使用 PCR 血清诊断和监测骨髓移植受者巨细胞病毒再激活。”Int J Hematol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takayama T., Kato J., et al: "Aberrant crypt foci of the colon as precursors of adenoma and cancer."New England Journal of Medicine. 339. 1277-1284 (1998)
Takayama T.、Kato J. 等人:“结肠的异常隐窝灶是腺瘤和癌症的前兆。”新英格兰医学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sakamaki S, Takayanagi N, Kato J, et al.: "Auto-antibodies against the specific epitope of human tropomyosin (s) detected by a peptide-based enzyme immunoassay in sera of patients with ulcerative colitis show antibody dependent cell-mediated cytotoxicity
Sakamaki S、Takayanagi N、Kato J 等人:“通过基于肽的酶免疫测定法在溃疡性结肠炎患者血清中检测到针对人原肌球蛋白特定表位的自身抗体,显示出抗体依赖性细胞介导的细胞毒性
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
13
    A novel ultrasound imaging for pancreatic cancer using tumor directed-contrast media
    • 批准号:
      24659372
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2012
    • 负责人:
      KATO Junji
    • 依托单位:
    Multiscale topology optimization for maximizing energy absorption capacity of composites
    • 批准号:
      23560561
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.16万
    • 财政年份:
      2011
    • 负责人:
      KATO Junji
    • 依托单位:
    Targeting anticancer drug delivery to pancreatic cancer cells using a fucose-bound nanoparticle approach
    • 批准号:
      21390231
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.4万
    • 财政年份:
      2009
    • 负责人:
      KATO Junji
    • 依托单位:
    Analyze of DNA repair gene in carcinogenesis from chronic hepatitis C
    • 批准号:
      19390202
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.98万
    • 财政年份:
      2007
    • 负责人:
      KATO Junji
    • 依托单位:
    国内基金
    海外基金
    新型全氟醚羧酸通过端粒缩短激活TGF-β/Smad 通路致儿童肾功能损伤的机制研究
    表观遗传调节因子BRD4调控TGF-β1相关纤维化基因和炎症因子参与腹膜透析相关性腹膜纤维化
    LOX通过激活TGF-β/SMAD通路介导糖尿病足溃疡难愈及复发的机制研究
    • 批准号:
      2026JJ82108
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      谭亮
    • 依托单位:
    基于上皮-间充质可塑性特征构建胶质瘤预后模型及靶向特定蛋白PTGFRN促进TGF-β/Smad3信号的机制研究